心脏再同步化治疗除颤器治疗终末期心力衰竭1例

刘 雅琳1, 李 颖2, 薛 玲*2
1、河北医科大学
2、河北医科大学第二医院鹿泉院区

摘要


慢性心力衰竭是许多心血管疾病的终末期表现和最主要的死因。在传统药物治疗的应用方面取得了显著发展，但其相关发病率、病死率及再住院率仍然偏高，生活质量也未见明显提高，为了更好地提高生活质量，器械治疗逐渐成为心衰患者潜在的治疗方案。为此本病例报道1例心脏再同步化治疗除颤器治疗终末期心力衰竭。

关键词


心力衰竭；扩张型心肌病；左束支传导阻滞；CRT-D；病例

全文:

PDF


参考


[1]Mahmaljy H, Yelamanchili VS, Singhal M. Dilated Cardiomyopathy. 2023 Apr 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. PMID: 28722940.

[2]Tomasoni D, Vishram-Nielsen JKK, Pagnesi M, Adamo M, Lombardi CM, Gustafsson F, Metra M. Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care. ESC Heart Fail. 2022 Jun;9(3):1507-1523. doi: 10.1002/ehf2.13859. Epub 2022 Mar 30. PMID: 35352499; PMCID: PMC9065830.

[3]Nguyen AH, Hurwitz M, Abraham J, Blumer V, Flanagan MC, Garan AR, Kanwar M, Kataria R, Kennedy JLW, Kochar A, Hernandez-Montfort J, Pahuja M, Shah P, Sherwood MW, Tehrani BN, Vallabhajosyula S, Kapur NK, Sinha SS. Medical Management and Device-Based Therapies in Chronic Heart Failure. J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101206. doi: 10.1016/j.jscai.2023.101206. PMID: 39131076; PMCID: PMC11308856.

[4]Mahmaljy H, Yelamanchili VS, Singhal M. Dilated Cardiomyopathy. 2023 Apr 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. PMID: 28722940.

[5]Ponnusamy SS, Vijayaraman P. Left Bundle Branch Block-Induced Cardiomyopathy: Insights From Left Bundle Branch Pacing. JACC Clin Electrophysiol. 2021 Sep;7(9):1155-1165. doi: 10.1016/j.jacep.2021.02.004. Epub 2021 Mar 31. PMID: 33812829.

[6]Vanderheyden M, Bartunek J. Cardiac resynchronization therapy in dyssynchronous heart failure: zooming in on cellular and molecular mechanisms. Circulation. 2009 Mar 10;119(9):1192-4. doi: 10.1161/CIRCULATIONAHA.108.841544. Epub 2009 Feb 23. PMID: 19237655.

[7]Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J, Sherfesee L, Wells GA, Tang AS. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013 Dec;34(46):3547-56. doi: 10.1093/eurheartj/eht290. Epub 2013 Jul 29. PMID: 23900696; PMCID: PMC3855551.

[8]Varma N, Boehmer J, Bhargava K, Yoo D, Leonelli F, Costanzo M, Saxena A, Sun L, Gold MR, Singh J, Gill J, Auricchio A. Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac Resynchronization Device Therapy. J Am Coll Cardiol. 2019 Nov 26;74(21):2588-2603. doi: 10.1016/j.jacc.2019.09.043. PMID: 31748196.

[9]Daubert C, Behar N, Martins RP, Mabo P, Leclercq C. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. Eur Heart J. 2017 May 14;38(19):1463-1472. doi: 10.1093/eurheartj/ehw270. PMID: 27371720.

[10]Naqvi SY, Jawaid A, Vermilye K, Biering-Sørensen T, Goldenberg I, Zareba W, McNitt S, Polonsky B, Solomon SD, Kutyifa V. Left Ventricular Reverse Remodeling in Cardiac Resynchronization Therapy and Long-Term Outcomes. JACC Clin Electrophysiol. 2019 Sep;5(9):1001-1010. doi: 10.1016/j.jacep.2019.07.012. PMID: 31537327.


Refbacks

  • 当前没有refback。